Dupha Formulations (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.70 M
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 2.50 M
- Revenue Growth -93.10%
- Profit Growth -59.62%
- Ebitda 97.06%
- Net Worth -4.27%
- Total Assets -16.10%
About Dupha Formulations (India)
Dupha Formulations (India) Private Limited (DFIPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2005 and has a history of 19 years and six months. Its registered office is in Ujjain, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajesh Singh, Deepak Rathore, Anupama Madan, and Two other members serve as directors at the Company.
Company Details
- Location
Ujjain, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U02423MP2005PTC017897
- Company No.
017897
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 2005
- Date of AGM
22 Apr 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Dupha Formulations (India)?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Singh  | Director | 25-Aug-2005 | Current |
| Deepak Rathore | Director | 25-Aug-2005 | Current |
| Anupama Madan | Director | 25-Aug-2005 | Current |
| Aruna Singh | Director | 25-Aug-2005 | Current |
| Viny Lahiri | Director | 25-Aug-2005 | Current |
Financial Performance of Dupha Formulations (India).
Dupha Formulations (India) Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 93.1% decrease. The company also saw a substantial fall in profitability, with a 59.62% decrease in profit. The company's net worth dipped by a decrease of 4.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dupha Formulations (India)?
In 2017, Dupha Formulations (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cure & Care Drugs Private LimitedRajesh Singh is a mutual person
Charges (Loans)
₹0
₹2.50 M
Charges Breakdown by Lending Institutions
- Uco Bank : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2007 | Uco Bank | ₹2.50 M | Satisfied |
How Many Employees Work at Dupha Formulations (India)?
Unlock and access historical data on people associated with Dupha Formulations (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dupha Formulations (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dupha Formulations (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.